Superior Treatment Response and In-field Tumor Control in Epidermal Growth Factor Receptor-mutant Genotype of Stage III Nonsquamous Non–Small cell Lung Cancer Undergoing Definitive Concurrent Chemoradiotherapy-Reference-Cited by-同舟云学术

Superior Treatment Response and In-field Tumor Control in Epidermal Growth Factor Receptor-mutant Genotype of Stage III Nonsquamous Non–Small cell Lung Cancer Undergoing Definitive Concurrent Chemoradiotherapy

Published:2017-05 Issue:3 Volume:18 Page:e169-e178
ISSN:1525-7304
Container-title:Clinical Lung Cancer
language:en
Short-container-title:Clinical Lung Cancer

Author:

Lim Yu Jin,Chang Ji Hyun,Kim Hak-Jae,Keam Bhumsuk,Kim Tae Min,Kim Dong-Wan,Paeng Jin Chul,Kang Keon Wook,Chung June-Key,Jeon Yoon Kyung,Chung Doo Hyun,Wu Hong-Gyun

Funder

National Research Foundation of Korea

Ministry of Health & Welfare, Republic of Korea

Ministry of Education, Science, and Technology

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference31 articles.

1. Cancer statistics, 2016;Siegel;CA Cancer J Clin,2016

2. Concurrent versus sequential chemoradiotherapy with cisplatin and vinorelbine in locally advanced non-small cell lung cancer: a randomized study;Zatloukal;Lung Cancer,2004

3. Phase II study of concurrent chemoradiotherapy with carboplatin and vinorelbine for locally advanced non-small-cell lung cancer;Ishida;Mol Clin Oncol,2014

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The ASCENT Trial: a phase 2 study of induction and consolidation afatinib and chemoradiation with or without surgery in stage III EGFR-mutant NSCLC;The Oncologist;2024-05-18

2. Clinical features and outcomes of unresectable locally advanced non-small cell lung cancer with uncommon EGFR Mutations: A retrospective multi-center Chinese study;2024-03-25

3. Targeted treatment for unresectable EGFR mutation-positive stage III non-small cell lung cancer: Emerging evidence and future perspectives;Lung Cancer;2024-01

4. Real-world treatment patterns and clinical outcomes in EGFR-mutant locally advanced lung adenocarcinoma: A multi-center cohort study;Journal of the National Cancer Center;2023-03

5. Pattern of failure and clinical value of local therapy for oligo‐recurrence in locally advanced non‐small cell lung cancer after definitive chemoradiation: Impact of driver mutation status;Cancer Medicine;2022-12-16